Latest Asx News

Terra Metals has raised $4 million through a strategic placement, attracting heavyweight investors to accelerate exploration at its Dante Project in Western Australia.

Metgasco Ltd has successfully raised approximately $750,000 through a partially underwritten entitlement offer to fund a production uplift program targeting its Odin and Vali gas fields in the Cooper Eromanga Basin.

Western Gold Resources has voluntarily suspended its shares from trading as it prepares to disclose details of a significant agreement and respond to an ASX price query.

African Gold Ltd has completed a strategic investment with Montage Gold Corp, involving a share swap and private placement worth approximately A$9.2 million, reshaping ownership stakes between the two miners.

Dimerix has reached a key milestone by dosing 200 adult patients in its Phase 3 ACTION3 trial for FSGS, progressing steadily toward full recruitment expected in late 2025.

Heavy Rare Earths Limited has validated a significant uranium anomaly at its Perenjori project in Western Australia, with soil assays reaching up to 116 ppm uranium. The company is preparing to drill and test this promising target, which compares favorably with established regional uranium deposits.

Newmont Corporation has updated its dividend announcement to clarify currency exchange rates and payment options for its upcoming Q1 2025 dividend, highlighting tax and payment logistics for investors.

Santana Minerals has announced a delay in submitting its Fast Track Approvals Application due to pending ecological consultant reports, missing the previously set June 30 deadline. The company remains optimistic about finalising the reports soon and prioritising the submission.

Syntara Limited reports encouraging interim Phase 2 data for its drug SNT-5505 combined with ruxolitinib, demonstrating significant symptom relief and spleen volume reduction in myelofibrosis patients. The company plans to engage the FDA soon to discuss pivotal trial design.

ASX Limited has finalised the sale of its investment in Digital Asset Holdings for $57 million, securing a substantial pre-tax gain that will bolster its FY25 financial results.

Syntara Limited is set to reveal fresh interim results from its Phase 2 trial of SNT-5505, targeting myelofibrosis, during an investor webinar ahead of a major European hematology conference.

Tivan Limited has made significant progress on a revised access road for its Speewah Fluorite Project, balancing infrastructure needs with cultural heritage preservation. The company also secured key native title agreements and regulatory approvals supporting its feasibility study and joint venture with Sumitomo Corporation.